The results of the 2-NBDG uptake assay and tubule formation assay also presented that LATS2 knockdown could reverse the impacts of melittin on the glycolysis and angiogenesis of NSCLC cells (Fig. 3C and D). The gene discussed is LATS2; the disease is non-small cell lung carcinoma.